An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says.

Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It’s important to avoid triggers and monitor ...

A man with asthma, an Asian man at home sitting on the couch breathing in an inhaler An anti-inflammation injectable can help asthma patients with airways clogged by mucus The number of patients with ...

Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more comfortably. But researchers at Karolinska Institutet have uncovered a surprising ...

In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...

For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...

A promising new drug for treating asthma could not only reduce asthma symptoms but also improve lung function in patients, according to a new study. The results of the trial involving dupilumab, which ...

Apr. 15—Patients in five states who have severe asthma and are covered by Blue Cross Blue Shield are facing a new obstacle to getting treatment. On Tuesday, BCBS began mandating that severe asthma ...

But in findings presented at the American College of Allergy, Asthma and Immunology (ACAAI) meeting in Orlando, the novel ...